DUBAI / WAM His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime ...
Read More »Novartis’s new CEO has cash, momentum for an overhaul
Asset swaps have been a big thing in pharma over the past few years. Now it’s time for the un-swap. Novartis AG said it was unwinding part of a complicated 2014 asset swap with GlaxoSmithKline PLC, trading its stake in their consumer-health joint venture for $13 billion. The decision isn’t a huge surprise, though the timing is unexpected. It suggests ...
Read More »